Clinical Trial Update: Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma? [NA]

View source ↗

Summary

This clinical trial investigates whether trogocytosis can serve as a predictive biomarker for CAR-T cell response in patients with diffuse large B-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Diffuse Large B Cell Lymphoma | NA | Status: RECRUITING